Fistulizing complications develop in approximately one third of patients with Crohn’s disease (CD), resulting in morbidity and impaired quality of life.


Crohn's Disease, Cutaneous Fistula, Gastrointestinal Agents, Immunosuppressive Agents, Intestinal Fistula, Mesenchymal Stem Cell Transplantation, Physiopathology, Rectal Fistula, Rectovaginal Fistula, therapeutic use, Therapy, Treatment Outcome, Urinary Fistula

Read More